These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
349 related items for PubMed ID: 33455926
1. Study protocol for a multicentre, 2×2 factorial, randomised, controlled trial evaluating the interest of intravenous iron and tranexamic acid to reduce blood transfusion in hip fracture patients (the HiFIT study). Lasocki S, Loupec T, Parot-Schinkel E, Vielle B, Danguy des Déserts M, Roquilly A, Lahlou-Casulli M, Collange V, Desebbe O, Duchalais A, Drugeon B, Bouzat P, Garrigue D, Mounet B, Hamard F, David JS, Leger M, Rineau E, HiFIT Study Group. BMJ Open; 2021 Jan 17; 11(1):e040273. PubMed ID: 33455926 [Abstract] [Full Text] [Related]
2. Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial. Lasocki S, Capdevila X, Vielle B, Bijok B, Lahlou-Casulli M, Collange V, Grillot N, Danguy des Deserts M, Duchalais A, Delannoy B, Drugeon B, Bouzat P, David JS, Rony L, Loupec T, Léger M, Rineau E, HiFIT Investigators, SFAR research network. Lancet Haematol; 2023 Sep 17; 10(9):e747-e755. PubMed ID: 37524101 [Abstract] [Full Text] [Related]
3. Tranexamic acid in hip fracture patients: a protocol for a randomised, placebo controlled trial on the efficacy of tranexamic acid in reducing blood loss in hip fracture patients. Gausden EB, Garner MR, Warner SJ, Levack A, Nellestein AM, Tedore T, Flores E, Lorich DG. BMJ Open; 2016 Jun 21; 6(6):e010676. PubMed ID: 27329438 [Abstract] [Full Text] [Related]
4. Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial. Tengberg PT, Foss NB, Palm H, Kallemose T, Troelsen A. Bone Joint J; 2016 Jun 21; 98-B(6):747-53. PubMed ID: 27235515 [Abstract] [Full Text] [Related]
5. Efficacy and tolerance of early administration of tranexamic acid in patients with cirrhosis presenting with acute upper gastrointestinal bleeding: a study protocol for a multicentre, randomised, double-blind, placebo-controlled trial (the EXARHOSE study). Heidet M, Amathieu R, Audureau E, Augusto O, Nicolazo de Barmon V, Rialland A, Schmitz D, Pierrang F, Marty J, Chollet-Xémard C, Thirion O, Jacob L. BMJ Open; 2018 Aug 10; 8(8):e021943. PubMed ID: 30099397 [Abstract] [Full Text] [Related]
6. Tranexamic ACid during PancereaticoDuodenectomy (TAC-PD): study protocol for a multicentre randomised, blind, placebo-controlled trial. Ishii K, Yokoyama Y, Yonekawa Y, Ebata T. BMJ Open; 2020 Nov 03; 10(11):e040914. PubMed ID: 33148764 [Abstract] [Full Text] [Related]
7. Study protocol: haemostatic efficacy and safety of preemptive antifibrinolysis with multidose intravenous tranexamic acid in elderly hip fracture patients: design of a prospective randomised controlled trial. Liu J, Lei Y, Liao J, Liang X, Hu N, Huang W. BMJ Open; 2021 Dec 14; 11(12):e047382. PubMed ID: 34907040 [Abstract] [Full Text] [Related]
8. Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial. Nikolaou VS, Masouros P, Floros T, Chronopoulos E, Skertsou M, Babis GC. Bone Joint J; 2021 Mar 14; 103-B(3):442-448. PubMed ID: 33641430 [Abstract] [Full Text] [Related]
9. Impact of intraosseous regional administration of tranexamic acid in total knee arthroplasty on perioperative blood loss: a protocol for a randomised controlled trial. Wei Z, Yu M, Xu Y, Weng X, Feng B. BMJ Open; 2024 Feb 12; 14(2):e077393. PubMed ID: 38346881 [Abstract] [Full Text] [Related]
10. Peroperative administration of tranexamic acid in Roux-en-Y and one-anastomosis gastric bypass to reduce haemorrhage in patients with morbid obesity: protocol for randomised controlled trial (PATRY trial). 't Hart JWH, Noordman BJ, Palsgraaf-Huisbrink J, Dunkelgrun M, Zengerink HF, Birnie E, van Det MJ, Boerma EG, de Castro SMM, Hazebroek EJ, Langenhoff BS, Verhoef C, Apers JA. BMJ Open; 2024 May 06; 14(5):e078853. PubMed ID: 38719323 [Abstract] [Full Text] [Related]
11. Efficacy and Safety of Tranexamic Acid in Intertrochanteric Fractures: A Single-Blind Randomized Controlled Trial. Zhou XD, Zhang Y, Jiang LF, Zhang JJ, Zhou D, Wu LD, Huang Y, Xu NW. Orthop Surg; 2019 Aug 06; 11(4):635-642. PubMed ID: 31419080 [Abstract] [Full Text] [Related]
15. Is intravenous tranexamic acid effective and safe during hip fracture surgery? An updated meta-analysis of randomized controlled trials. Xiao C, Zhang S, Long N, Yu W, Jiang Y. Arch Orthop Trauma Surg; 2019 Jul 06; 139(7):893-902. PubMed ID: 30637503 [Abstract] [Full Text] [Related]
16. Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis: A meta-analysis. Zhang P, He J, Fang Y, Chen P, Liang Y, Wang J. Medicine (Baltimore); 2017 May 06; 96(21):e6940. PubMed ID: 28538384 [Abstract] [Full Text] [Related]